Vitamin D supplementation for the prevention or depletion of side effects of therapy with alemtuzumab in multiple sclerosis

PURPOSE OF REVIEW: Not only the multiple sclerosis specialist but also the general neurologist and primary care practitioner are increasingly aware of possible adverse events (AEs) by treatment with alemtuzumab (over 47% risk of secondary autoimmune-mediated diseases). Vitamin D supplementation'...

Descripción completa

Detalles Bibliográficos
Autor principal: Goischke, Hans-Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636607/
https://www.ncbi.nlm.nih.gov/pubmed/31371976
http://dx.doi.org/10.2147/TCRM.S188941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636607/
https://www.ncbi.nlm.nih.gov/pubmed/31371976
http://dx.doi.org/10.2147/TCRM.S188941

Ejemplares similares